Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Present at UBS Global Healthcare Services Conference

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2005--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that Chairman, President and Chief Executive Officer James C. Foster will present at the UBS 2005 Global Healthcare Services Conference in New York, N.Y., on Wednesday, February 16, 2005 at 11:00 a.m. E.T.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay will be accessible through the same website approximately three hours after the presentation and will remain available until February 23, 2005.

CONTACT: Charles River Laboratories
Investor Relations Contact:
Susan E. Hardy, 978-658-6000 Ext. 1616

SOURCE: Charles River Laboratories

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)